FDA Issues Serious Warning to Patients Taking Tavneos

Originally published by our sister publication Gastroenterology & Endoscopy NewsBy GEN StaffThe FDA recently issued a warning related to avacopan (Tavneos, Amgen) after the drug was found to be associated with serious cases of drug-induced liver injuries, some fatal and some involving vanishing bile duct syndrome, which can lead to permanent liver damage.“Although hepatoxicity is a serious adverse reaction for Tavneos identified in premarket clinical trials and described in product lab